FDA Warning Letters Released The Weeks Of Sept. 17 And Sept. 24
This article was originally published in The Gray Sheet
CardioMEMS receives warning letter citing sponsor violations related to the CHAMPION trial of its heart failure pressure measurement system.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.